<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
OXBORO MEDICAL INTERNATIONAL, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Minnesota 41-1391803
------------- -------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
13828 Lincoln Street NE
Ham Lake, Minnesota 55304
----------------------- ----------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act: None
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box. / /
If this Form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box. /X/
Securities Act registration statement file number to which this form relates:
333-83469
Securities to be registered pursuant to Section 12(g) of the Act:
Warrants
--------
Title of Class
<PAGE>
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
On July 22, 1999, the Issuer, Oxboro Medical International, Inc., filed
a Registration Statement on Form S-3 (File No. 333-83469) with the Securities
and Exchange Commission to register (i) rights to purchase shares of Common
Stock and Warrants, (ii) shares of its Common Stock, having $.01 par value
per share, to be issued upon exercise of the rights, (iii) one-year Warrants
exercisable for purchase of Common Stock (the "Warrants"), and (iv) shares of
Common Stock of the Issuer underlying the Warrants. Each Warrant is
exercisable from and after the date of issuance for purchase of one share of
Common Stock of the Issuer at an exercise price of $2.75 per Warrant. Each
Warrant expires one year from the date of issuance. The Issuer's Registration
Statement, as amended, the related Prospectus dated September 1, 1999, as
filed pursuant to Rule 424(b), and the Prospectus Supplement dated October 5,
1999, are deemed to be incorporated by reference herein with respect to the
Warrants.
Item 2. EXHIBITS.
The following exhibits are incorporated by reference to the respective
Exhibits of the same number in Oxboro's Registration Statement on Form S-3 filed
with the Securities and Exchange Commission on July 22, 1999 and as subsequently
amended:
3(a) Articles of Incorporation of Oxboro, as amended
3(b) Bylaws of Oxboro, as amended
on the effective date of the offering
4(e) Form of Warrant Certificate
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
OXBORO MEDICAL INTERNATIONAL, INC.
Dated: November 16, 1999 By /s/ Matthew E. Bellin
-----------------------------------
Matthew E. Bellin, President
Page 2 of 2
